Why a hot startup open-sourced their most in-demand technology during COVID19 Octant Bio, an Ulu portfolio company, uses synthetic biology to advance computational drug discovery.
An Ulu Ventures Interview with Errette Dunn CEO/Co-Founder Rever Rusty Dornin, Ulu Ventures: We are pretty excited about Rever and just made an investment. It’s
Buzz Solutions ensures our digital lives have power by helping utilities analyze their infrastructure to detect faults, to highlight areas of risk, and to generally
On a good day, managing liquidity and accessing capital are top three topics for company CEOs and CFOs. In the current environment, it’s either number